Invention Grant
US09128103B2 Mid-regional pro-atrial natriuretic peptide (pro-ANP) for the identification of patients with atrial fibrillation with an onset of less than 48 hours ago
有权
用于鉴定心房颤动患者的中部区域性钠尿钠肽（pro-ANP），起病时间小于48小时前
- Patent Title: Mid-regional pro-atrial natriuretic peptide (pro-ANP) for the identification of patients with atrial fibrillation with an onset of less than 48 hours ago
- Patent Title (中): 用于鉴定心房颤动患者的中部区域性钠尿钠肽（pro-ANP），起病时间小于48小时前
-
Application No.: US14235561Application Date: 2012-07-02
-
Publication No.: US09128103B2Publication Date: 2015-09-08
- Inventor: Christophe Meune
- Applicant: Christophe Meune
- Applicant Address: DE Hennigsdorf
- Assignee: B.R.A.H.M.S. GmbH
- Current Assignee: B.R.A.H.M.S. GmbH
- Current Assignee Address: DE Hennigsdorf
- Agency: Wood, Herron & Evans, LLP
- Priority: EP11352009 20110728
- International Application: PCT/EP2012/002778 WO 20120702
- International Announcement: WO2013/013758 WO 20130131
- Main IPC: G01N33/53
- IPC: G01N33/53 ; G01N33/68
Abstract:
The invention relates to a method for the determination of the time from onset of atrial fibrillation to presentation in a patient comprising the steps of: providing a sample of a bodily fluid of said patient, determining the level of proANP (SEQ ID NO: 1) or fragments thereof in said sample, correlating the level of proANP or fragments thereof to the time from the onset of atrial fibrillation to presentation of said patient, wherein said fragments have a length of at least 6 amino acid residues.
Public/Granted literature
Information query
IPC分类:
